Open Access journals get impressive impact factors

June 23, 2005

Impressive impact factors prove that BioMed Central's Open Access journals are high quality and widely read and cited. Journals published by BioMed Central have again received impact factors that compare well with equivalent subscription titles, it was announced today, with five titles in the top five of their specialty. The high impact factors for these journals affirm that they are respected by researchers, and are fast becoming the place for authors to submit important research findings.

Five journals published by BioMed Central received their first impact factors this year. BMC Bioinformatics, with an impact factor of 5.42, has reinforced its reputation as one of the top journals in its field. Launched in 2000, it is the second highest ranked bioinformatics journal, and already has an impact factor comparable to that of Bioinformatics (5.74), the most established journal in the field, which has been publishing for more than two decades and is supported by a major society.

BMC Genomics enters the Journal Citation Report with a respectable 3.25. This puts it in the top third of the genetics titles, and the top 20% of biotechnology journals. BMC Molecular Biology has an impact factor of 3.12, and BMC Musculoskeletal Disorders an impact factor of 1.00, putting it in the top half of the orthopaedics listing. BMC Genetics has an impact factor of 0.92.

Critical Care's impact factor jumped from 1.9 to 3.21, and the journal is now third in the critical care medicine field having leap-frogged the competitor title Intensive Care Medicine, the official journal of the major European society. Breast Cancer Research also increased it's impact factor from 2.93 to 2.98 and remains the second highest ranking breast cancer journal. Arthritis Research & Therapy maintains its rank of second in the rheumatology field with an impact factor of 4.55.

A number of other journal published by BioMed Central also saw their impact factors and rankings improve. BMC Infectious Diseases jumped from 1.25 to 2.07. BMC Cell Biology, with an impact factor of 2.62, is now in the top half of the cell biology listing. The impact factor for BMC Health Services Research almost doubled, from 0.68 to 1.23. BMC Cancer went up from 1.70 to 2.29 and BMC Public Health now has an impact factor of 1.55. With an impact factor of 4.03, Respiratory Research is the fifth most cited journal in the highly competitive respirology field.

The impact factors, which are calculated by ISI, look at citations in 2004 of articles published in the journals in the period 2002-2003. According to Dr Matthew Cockerill, Director of Operations at BioMed Central, "These latest impact factors show that BioMed Central's Open Access journals have joined the mainstream of science publishing, and can compete with traditional journals on their own terms. The impact factors also demonstrate one of the key benefits that Open Access offers authors: high visibility and, as a result, a high rate of citation."
-end-
Press Office Contacts:

Grace Baynes for BioMed Central
Telephone: 44-207-631-9988
E-mail: press@biomedcentral.com

About BioMed Central
BioMed Central (http://www.biomedcentral.com) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science. In addition to open-access original research, BioMed Central also publishes reviews and other subscription-based content.

About the BMC-series
The journals with "BMC" in their title are part of the "BMC-series"; a collection of peer-reviewed, research-only Open Access journals that span biomedicine. The medical journals within the series, such as BMC Musculoskeletal Disorders, operate an open peer review policy whereby reviewers sign their reports, which are then made available online as part of a "pre-publication history".

* Institute for Scientific Information (ISI), Philadelphia, USA. Journal Citation Report, 2004.

BioMed Central

Related Bioinformatics Articles from Brightsurf:

Glyphosate may affect human gut microbiota
More than half of bacterial species in the core of the human gut microbiome are potentially sensitive to glyphosate, shows new research.

Next-gen bioinformatics tool enables big data analysis without programming expertise
A new data analysis tool developed by MD Anderson researchers incorporates a user-friendly, natural-language interface to aid biomedical researchers without bioinformatics or programming expertise to conduct intuitive data.

Embracing bioinformatics in gene banks
Scientists from the IPK have explored, within a perspective paper, the upcoming challenges and possibilities of the future of gene banks.

New bioinformatics tool identifies and classifies CRISPR-Cas systems
Designed to improve the utility and availability of increasingly diverse CRISPR-Cas genome editing systems, the new CRISPRdisco automated pipeline helps researchers identify CRISPR repeats and cas genes in genome assemblies.

AMP Iissues consensus guideline recommendations for NGS bioinformatics pipelines
The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better patient care.

Advances: Bioinformatics applied to development & evaluation of boron-containing compounds
The interest for developing boron-containing compounds as drugs is increasing after some successful cases.

When life sciences become data sciences
The University of Freiburg offers Europe-wide infrastructure and service in Bioinformatics.

Bioinformatics brings to light new combinations of drugs to fight breast cancer
A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.

New bioinformatics tool tests methods for finding mutant genes that 'drive' cancer
Computational scientists and cancer experts have devised bioinformatics software to evaluate how well current strategies distinguish cancer-promoting mutations from benign mutations in cancer cells.

EDGE bioinformatics brings genomics to everyone
A new bioinformatics platform called Empowering the Development of Genomics Expertise (EDGE) will help democratize the genomics revolution by allowing users with limited bioinformatics expertise to quickly analyze and interpret genomic sequence data.

Read More: Bioinformatics News and Bioinformatics Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.